The Motley Fool

Should you buy Vision Eye Institute Ltd shares today?

Vision Eye Institute Ltd (ASX: VEI) has reported its results for the year ended 30 June 2015, revealing a 2.1% increase in revenue and a 22.6% increase in underlying net profit after tax (NPAT).

The group’s revenue rose to $112.9 million, while its underlying NPAT lifted to $14.5 million, although the reported profit actually fell 8.9% compared to the prior year. This was impacted by a $2.5 million goodwill write-down (related to Gold Coast clinics which have recently been sold) and a $1.9 million insurance claim that benefited the group’s overall earnings in the 2014 financial year (FY14).

Despite the results, the share price barely budged with the stock ending the day at $1.07. This is because of an all-cash takeover offer recently launched by the Shanghai-listed Jangho Group.

Jangho, which recently purchased a 19.99% stake in the business from Primary Health Care Limited (ASX: PRY), offered to pay $1.10 in cash per share for each of the shares it doesn’t already own, exceeding the 88 cent per share bid previously lodged by Pulse Health Limited (ASX: PHG).

While the deal is no certainty to go ahead, Vision Eye’s Board of directors unanimously recommended that shareholders accept the offer in the absence of any superior proposals. Unfortunately for investors, the board has also established that a payment of a special dividend in conjunction with the takeover offer was not feasible.

With Vision Eye’s shares trading within 3 cents of Jangho’s bid-price, investors may be better off looking for superior investment opportunities elsewhere. Thanks to the market’s recent crash, ASX stocks haven’t looked this appealing in years…

NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading over 40% off its high, all while offering a fully franked dividend yield over 3%...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.


Motley Fool contributor Ryan Newman has no position in any stocks mentioned. 

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.